Teva Pharmaceutical Industries Ltd.
GPTKB entity
Properties (46)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
Actavis Generics
Allergan's generics business |
gptkbp:awards |
recognized for innovation in pharmaceuticals
received awards for corporate responsibility received awards for environmental sustainability efforts awarded for diversity and inclusion initiatives won accolades for workplace culture |
gptkbp:CEO |
Kåre Schultz
|
gptkbp:communityEngagement |
volunteer programs for employees
involved in educational programs supports various health initiatives donates to health-related charities supports local communities through grants |
gptkbp:employees |
over 40,000
|
gptkbp:founded |
1901
|
gptkbp:founder |
Salomon,_A._A._Teva
|
gptkbp:globalPresence |
operates in over 60 countries
|
gptkbp:headCoach |
over 40,000
|
gptkbp:headquarters |
Petah_Tikva,_Israel
|
https://www.w3.org/2000/01/rdf-schema#label |
Teva Pharmaceutical Industries Ltd.
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:legalStatus |
faced multiple lawsuits regarding opioid crisis
settled with multiple states over opioid-related claims |
gptkbp:market |
$10.5 billion (2021)
|
gptkbp:notableFeature |
gptkb:Vascepa
Procrit Ajovy Treanda Copaxone |
gptkbp:partnerships |
partnerships with various biotech firms
|
gptkbp:products |
Specialty medicines
Generic_drugs |
gptkbp:researchAndDevelopment |
invests heavily in R&D
|
gptkbp:revenue |
$16.7 billion (2020)
|
gptkbp:stockExchange |
gptkb:NYSE
|
gptkbp:stockSymbol |
gptkb:TEVA
|
gptkbp:subsidiary |
gptkb:Teva_Canada_Limited
gptkb:Teva_Pharmaceuticals_Europe_B.V. gptkb:Teva_USA |
gptkbp:sustainability |
water conservation efforts
committed to sustainable practices focus on reducing carbon footprint aims for zero waste to landfill by 2025 initiatives for responsible sourcing |
gptkbp:website |
www.tevapharm.com
|